Danaher Gross Margin 2010-2024 | DHR

Current and historical gross margin for Danaher (DHR) over the last 10 years. The current gross profit margin for Danaher as of December 31, 2024 is %.
Danaher Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-12-31 $23.88B $14.21B 59.50%
2024-09-30 $23.74B $14.10B 59.37%
2024-06-30 $23.57B $13.97B 59.27%
2024-03-31 $23.74B $13.86B 58.39%
2023-12-31 $23.89B $14.03B 58.74%
2023-09-30 $21.03B $12.43B 59.13%
2023-06-30 $23.07B $13.74B 59.58%
2023-03-31 $24.90B $15.15B 60.81%
2022-12-31 $26.64B $16.19B 60.76%
2022-09-30 $26.60B $16.24B 61.05%
2022-06-30 $26.17B $16.02B 61.21%
2022-03-31 $25.63B $15.69B 61.22%
2021-12-31 $24.80B $15.24B 61.44%
2021-09-30 $28.07B $16.96B 60.44%
2021-06-30 $26.72B $15.83B 59.24%
2021-03-31 $24.80B $14.29B 57.60%
2020-12-31 $22.28B $12.48B 55.98%
2020-09-30 $20.39B $11.23B 55.05%
2020-06-30 $18.89B $10.44B 55.28%
2020-03-31 $18.03B $10.07B 55.85%
2019-12-31 $17.91B $9.98B 55.74%
2019-09-30 $15.56B $8.63B 55.48%
2019-06-30 $16.04B $8.88B 55.39%
2019-03-31 $16.57B $9.22B 55.61%
2018-12-31 $17.05B $9.51B 55.76%
2018-09-30 $16.80B $9.37B 55.76%
2018-06-30 $16.48B $9.22B 55.93%
2018-03-31 $16.01B $8.88B 55.48%
2017-12-31 $15.52B $8.57B 55.23%
2017-09-30 $17.83B $9.85B 55.27%
2017-06-30 $17.43B $9.60B 55.08%
2017-03-31 $17.16B $9.50B 55.35%
2016-12-31 $16.88B $9.33B 55.29%
2016-09-30 $13.57B $7.60B 56.02%
2016-06-30 $12.95B $7.21B 55.67%
2016-03-31 $13.66B $7.47B 54.67%
2015-12-31 $14.43B $7.77B 53.83%
2015-09-30 $18.58B $9.81B 52.78%
2015-06-30 $19.78B $10.37B 52.42%
2015-03-31 $19.78B $10.34B 52.29%
2014-12-31 $19.75B $10.33B 52.30%
2014-09-30 $19.60B $10.24B 52.23%
2014-06-30 $19.56B $10.21B 52.19%
2014-03-31 $19.34B $10.09B 52.16%
2013-12-31 $19.12B $9.96B 52.09%
2013-09-30 $18.83B $9.79B 52.01%
2013-06-30 $18.57B $9.65B 51.93%
2013-03-31 $18.39B $9.51B 51.69%
2012-12-31 $18.26B $9.42B 51.56%
2012-09-30 $18.00B $9.20B 51.09%
2012-06-30 $18.03B $9.10B 50.47%
2012-03-31 $17.12B $8.66B 50.62%
2011-12-31 $16.09B $8.18B 50.82%
2011-09-30 $14.61B $7.57B 51.81%
2011-06-30 $13.25B $7.00B 52.80%
2011-03-31 $12.83B $6.69B 52.09%
2010-12-31 $12.55B $6.41B 51.04%
2010-09-30 $11.78B $5.92B 50.20%
2010-06-30 $11.44B $5.62B 49.16%
2010-03-31 $10.90B $5.28B 48.45%
2009-12-31 $10.52B $5.07B 48.20%
Sector Industry Market Cap Revenue
Medical Medical Services $151.685B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $90.559B 11.84
Cencora (COR) United States $47.572B 17.32
Natera (NTRA) United States $23.122B 0.00
DiDi Global (DIDIY) China $22.844B 0.00
ICON (ICLR) Ireland $16.164B 14.40
Avantor (AVTR) United States $14.769B 22.14
Revvity (RVTY) United States $14.502B 24.32
BioMerieux (BMXMF) France $14.256B 0.00
Viatris (VTRS) United States $13.010B 4.01
Solventum (SOLV) United States $12.919B 0.00
CochLear (CHEOY) Australia $12.848B 0.00
Medpace Holdings (MEDP) United States $11.220B 31.61
Doximity (DOCS) United States $10.877B 56.56
EUROFINS SCIENT (ERFSF) Luxembourg $10.037B 0.00
HealthEquity (HQY) United States $9.712B 48.73
Sonic Healthcare (SKHHY) Australia $8.513B 0.00
Charles River Laboratories (CRL) United States $8.502B 16.43
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
Bausch + Lomb (BLCO) Canada $5.661B 26.33
BrightSpring Health Services (BTSG) United States $3.913B 83.22
Sotera Health (SHC) United States $3.909B 20.91
Organon (OGN) United States $3.835B 3.87
Surgery Partners (SGRY) United States $3.260B 37.17
Concentras Parent (CON) United States $2.958B 0.00
Alignment Healthcare (ALHC) United States $2.885B 0.00
PACS (PACS) United States $2.161B 0.00
Ardent Health Partners (ARDT) United States $2.121B 0.00
Teladoc Health (TDOC) United States $2.061B 0.00
Progyny (PGNY) United States $1.859B 37.64
GoodRx Holdings (GDRX) United States $1.837B 48.20
Premier (PINC) United States $1.821B 11.08
GeneDx Holdings (WGS) United States $1.708B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.409B 0.00
Agilon Health (AGL) United States $1.351B 0.00
CareDx (CDNA) United States $1.217B 0.00
Pediatrix Medical (MD) United States $1.177B 11.51
Embecta (EMBC) United States $1.031B 7.06
AMN Healthcare Services Inc (AMN) United States $0.993B 6.72
Establishment Labs Holdings (ESTA) $0.848B 0.00
Auna S.A (AUNA) Luxembourg $0.602B 0.00
SBC Medicals (SBC) United States $0.533B 0.00
DocGo (DCGO) United States $0.501B 18.89
Sonida Senior Living (SNDA) United States $0.464B 0.00
InnovAge Holding (INNV) United States $0.435B 0.00
Enhabit (EHAB) United States $0.414B 35.83
QDM (QDMI) Hong Kong, SAR China $0.382B 10.00
MultiPlan (MPLN) United States $0.352B 0.00
Nutex Health (NUTX) United States $0.323B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.317B 0.00
LifeMD (LFMD) United States $0.270B 0.00
Beauty Health (SKIN) United States $0.201B 0.00
Performant Healthcare (PHLT) United States $0.185B 0.00
Sera Prognostics (SERA) United States $0.159B 0.00
Biodesix (BDSX) United States $0.151B 0.00
So-Young (SY) China $0.104B 17.63
Ascend Wellness Holdings (AAWH) United States $0.086B 0.00
IceCure Medical (ICCM) Israel $0.072B 0.00
Oncology Institute (TOI) United States $0.067B 0.00
ModivCare (MODV) United States $0.062B 3.35
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Co-Diagnostics (CODX) United States $0.022B 0.00
Pheton Holdings (PTHL) China $0.019B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00